Armada Acquisition Corp. III Units · AACIU

Exhibit 99.1 Armada Acquisition Corp. III and Brains Bioceutical Corp. Announce Business Combination to Advance a Global Life Sciences and Pharmaceutical Innovation Platform Proposed Nasdaq listing to accelerate Brains’ pharmaceutical API manufacturing, drug development, regulatory science and commercialization strategy Brains combines established European pharmaceutical manufacturing infrastructure with a diversified portfolio of proprietary and partnered drug-development programs Transacti…

8-K · 2026-11-05 · 0001193125-26-449772

Exhibit 99.2 I N V E S T O R P R E S E N T A T I O N D O C U M E N T N O. B B - I P - 2 0 2 6 - 0 0 2 · V E R S I O N 4.6 Disclaimer D O C U M E N T N O. B B - I P - 2 0 2 6 - 0 0 2 · V E R S I O N 4.6 D I S C L A I M E R employees, advisers or agents shall be responsible or liable for any direct, indirect or about Brains and AACI through the website maintained by the SEC at www.sec.gov. consequential loss or loss of profit arising from the use of this Presentation, its contents, This presentat…

8-K · 2026-11-05 · 0001193125-26-449772

Exhibit 10.7 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of the [x] day of [x], 2025, by and among Armada Acquisition Corp. III, a Cayman Islands exempted company (the “Company”), Armada Sponsor III, LLC, a Delaware limited liability company (the “Sponsor”), Cohen and Company Capital Markets a division of Cohen & Company Securities, LLC (“CCM”), and Northland Securities, Inc. (“Northland”, and together with CCM, the “Representatives”) …

S-1/A · 2026-02-09 · 0001193125-26-042109

Exhibit 4.4 WARRANT AGREEMENT This Warrant Agreement is made as of [ ] between Armada Acquisition Corp. III, a Cayman Islands exempted company, with offices at 1760 Market Street, Suite 602, Philadelphia, PA 19103 (“Company”), and Continental Stock Transfer & Trust Company, a New York limited purpose trust company, with offices at 1 State Street, New York, New York 10004 (“Warrant Agent”). WHEREAS, on [ ], the Company entered into that certain Private Placement Unit Purchase Agreement with ea…

S-1/A · 2026-02-09 · 0001193125-26-042109

Exhibit 4.1 NUMBER U- SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP [   ] ARMADA ACQUISITION CORP. III UNITS CONSISTING OF ONE CLASS A ORDINARY SHARE AND ONE-HALF OF ONE REDEEMABLE WARRANT, EACH WHOLE WARRANT ENTITLING THE HOLDER TO PURCHASE ONE CLASS A ORDINARY SHARE THIS CERTIFIES THAT is the owner of Units. Each Unit (“Unit”) consists of one (1) Class A ordinary shares, par value $0.0001 per share (the “Ordinary Shares”), of Armada Acquisition Corp. III, a Cayman Islands exempted company…

S-1/A · 2026-01-28 · 0001193125-26-025221

Exhibit 4.2 SHARES CUSIP G0R38G 104 NUMBER C- SEE REVERSE FOR CERTAIN DEFINITIONS ARMADA ACQUISITION CORP. III INCORPORATED UNDER THE LAWS OF THE CAYMAN ISLANDS CLASS A ORDINARY SHARES THIS CERTIFIES THAT          is the owner of FULLY PAID AND NON-ASSESSABLE CLASS A ORDINARY SHARES OF PAR VALUE OF $0.0001 EACH (the “Ordinary Shares”) OF ARMADA ACQUISITION CORP. III (the “Company”), transferable on the books of the Company in person or by duly authorized attorney upon surrender of …

S-1/A · 2026-01-28 · 0001193125-26-025221